Statins and Renin Angiotensin System Inhibitors Dose-Dependently Protect Hypertensive Patients against Dialysis Risk

about

Statins and Renin Angiotensin System Inhibitors Dose-Dependently Protect Hypertensive Patients against Dialysis Risk

Item

http://www.wikidata.org/entity/Q28554193

description

2016 nî lūn-bûn

@nan

2016 թուականին հրատարակուած գիտական յօդուած

@hyw

2016 թվականին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Statins and Renin Angiotensin ...... Patients against Dialysis Risk

@ast

Statins and Renin Angiotensin ...... Patients against Dialysis Risk

@en

Statins and Renin Angiotensin ...... Patients against Dialysis Risk

@nl

type

Item

label

Statins and Renin Angiotensin ...... Patients against Dialysis Risk

@ast

Statins and Renin Angiotensin ...... Patients against Dialysis Risk

@en

Statins and Renin Angiotensin ...... Patients against Dialysis Risk

@nl

prefLabel

Statins and Renin Angiotensin ...... Patients against Dialysis Risk

@ast

Statins and Renin Angiotensin ...... Patients against Dialysis Risk

@en

Statins and Renin Angiotensin ...... Patients against Dialysis Risk

@nl

P1476

Statins and Renin Angiotensin ...... Patients against Dialysis Risk

@en

P2093

Ju-Chi Liu

http://www.w3.org/2001/XMLSchema#string

Yi-Ping Hsu

http://www.w3.org/2001/XMLSchema#string

P2860

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis

Chronic kidney disease of uncertain aetiology: prevalence and causative factors in a developing country

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data.

Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials

Excerpts from the US Renal Data System 2009 Annual Data Report.

The clinical epidemiology of cardiac disease in chronic renal failure.

Relation of serum lipids and lipoproteins with progression of CKD: The CRIC study.

Progression of kidney disease in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin versus usual care: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

P304

e0162588

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3510728

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PONE.0162588

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Szu-Yuan Wu

P577

2016-09-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27632175

http://www.w3.org/2001/XMLSchema#string

P921

renal dialysis

P932

5025231

http://www.w3.org/2001/XMLSchema#string